BMC Cardiovascular Disorders (Jun 2020)

Population attributable risk estimates of risk factors for contrast-induced acute kidney injury following coronary angiography: a cohort study

  • Li Lei,
  • Yan Xue,
  • Zhaodong Guo,
  • Bowen Liu,
  • Yibo He,
  • Feier Song,
  • Jin Liu,
  • Guoli Sun,
  • Liling Chen,
  • Kaihong Chen,
  • Zhiqi Su,
  • Li Pan,
  • Zhidong Huang,
  • Yulu Huang,
  • Xiuqiong Huang,
  • Shiqun Chen,
  • Jiyan Chen,
  • Yong Liu

DOI
https://doi.org/10.1186/s12872-020-01570-6
Journal volume & issue
Vol. 20, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Background Contrast-induced acute kidney injury (CI-AKI) is a common complication with poor outcomes following coronary angiography (CAG) or percutaneous coronary intervention (PCI). However, no study has explored the population attributable risks (PARs) of the CI-AKI risk factors. Therefore, we aimed to identify the independent risk factors of CI-AKI and estimate their PARs. Methods We analyzed 3450 consecutive patients undergoing CAG/PCI from a prospective cohort in Guangdong Provincial People’s Hospital. CI-AKI was defined as a serum creatinine elevation ≥50% or 0.3 mg/dL from baseline within the first 48 to 72 h after the procedure. Independent risk factors for CI-AKI were evaluated through stepwise approach and multivariable logistic regression analysis, and those that are potentially modifiable were of interest. PARs of independent risk factors were calculated with their odds ratios and prevalence among our cohort. Results The overall incidence of CI-AKI was 7.19% (n = 248), which was associated with increased long-term mortality. Independent risk factors for CI-AKI included heart failure (HF) symptoms, hypoalbuminemia, high contrast volume, hypotension, hypertension, chronic kidney disease stages, acute myocardial infarction and age > 75 years. Among the four risk factors of interest, the PAR of HF symptoms was the highest (38.06%), followed by hypoalbuminemia (17.69%), high contrast volume (12.91%) and hypotension (4.21%). Conclusions These modifiable risk factors (e.g., HF symptoms, hypoalbuminemia) could be important and cost-effective targets for prevention and treatment strategies to reduce the risk of CI-AKI. Intervention studies targeting these risk factors are needed.

Keywords